We are analyzing https://link.springer.com/article/10.1007/s00401-016-1569-6.

Title:
Risk stratification of childhood medulloblastoma in the molecular era: the current consensus | Acta Neuropathologica
Description:
Historical risk stratification criteria for medulloblastoma rely primarily on clinicopathological variables pertaining to age, presence of metastases, extent of resection, histological subtypes and in some instances individual genetic aberrations such as MYC and MYCN amplification. In 2010, an international panel of experts established consensus defining four main subgroups of medulloblastoma (WNT, SHH, Group 3 and Group 4) delineated by transcriptional profiling. This has led to the current generation of biomarker-driven clinical trials assigning WNT tumors to a favorable prognosis group in addition to clinicopathological criteria including MYC and MYCN gene amplifications. However, outcome prediction of non-WNT subgroups is a challenge due to inconsistent survival reports. In 2015, a consensus conference was convened in Heidelberg with the objective to further refine the risk stratification in the context of subgroups and agree on a definition of risk groups of non-infant, childhood medulloblastoma (ages 3–17). Published and unpublished data over the past 5 years were reviewed, and a consensus was reached regarding the level of evidence for currently available biomarkers. The following risk groups were defined based on current survival rates: low risk (>90 % survival), average (standard) risk (75–90 % survival), high risk (50–75 % survival) and very high risk (<50 % survival) disease. The WNT subgroup and non-metastatic Group 4 tumors with whole chromosome 11 loss or whole chromosome 17 gain were recognized as low-risk tumors that may qualify for reduced therapy. High-risk strata were defined as patients with metastatic SHH or Group 4 tumors, or MYCN-amplified SHH medulloblastomas. Very high-risk patients are Group 3 with metastases or SHH with TP53 mutation. In addition, a number of consensus points were reached that should be standardized across future clinical trials. Although we anticipate new data will emerge from currently ongoing and recently completed clinical trials, this consensus can serve as an outline for prioritization of certain molecular subsets of tumors to define and validate risk groups as a basis for future clinical trials.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Education
Insurance
Science

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 7,642,828 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We don't see any clear sign of profit-making.

Some websites aren't about earning revenue; they're built to connect communities or raise awareness. There are numerous motivations behind creating websites. This might be one of them. Link.springer.com might be earning cash quietly, but we haven't detected the monetization method.

Keywords {🔍}

pubmed, article, medulloblastoma, google, scholar, cas, oncol, central, clin, group, molecular, remke, clinical, doijco, cancer, northcott, risk, acta, kool, ramaswamy, subgroups, neuropathol, dois, oncology, pediatric, department, stratification, consensus, taylor, survival, chemotherapy, trial, korshunov, nature, wnt, shh, tumors, outcome, children, childhood, robinson, therapy, patients, access, study, childrens, doinature, university, germany, data,

Topics {✒️}

katja von hoff medulloblastoma subgroup-specific outcomes month download article/chapter distinct genetic profiles beta-catenin status predicts shh/wnt molecular subgroups integrated genomics identifies subgroup-specific structural variation siop/ukccsg pnet-3 chemotherapy phase iii study p53 defects emerge vijay ramaswamy wnt/wingless pathway activation improved clinico-molecular stratification german cancer consortium full article pdf related subjects mycn-amplified shh medulloblastomas biomarker-driven stratification risk-adapted craniospinal radiotherapy 1093/neuonc/nos267 pei subgroup-specific prognostic implications disease-risk stratification groups true high-risk patients article ramaswamy clinical heterogeneity pugh tj national medical center privacy choices/manage cookies prognostic factors nicolas andr� check access formalin-fixed biopsies instant access newly diagnosed medulloblastoma favorable prognosis group specific genetic alterations stem-cell rescue prospective observational study hyperfractionated accelerated radiotherapy 1007/s00401-011-0922 risk-adapted therapy cancer research future clinical trials myc-driven medulloblastoma european economic area future medulloblastoma trials cancer cell 27 cancer cell 25 cancer cell 29

Questions {❓}

Ramaswamy V, Remke M, Adamski J, Bartels U, Tabori U, Wang X et al (2016) Medulloblastoma subgroup-specific outcomes in irradiated children: who are the true high-risk patients?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Risk stratification of childhood medulloblastoma in the molecular era: the current consensus
         description:Historical risk stratification criteria for medulloblastoma rely primarily on clinicopathological variables pertaining to age, presence of metastases, extent of resection, histological subtypes and in some instances individual genetic aberrations such as MYC and MYCN amplification. In 2010, an international panel of experts established consensus defining four main subgroups of medulloblastoma (WNT, SHH, Group 3 and Group 4) delineated by transcriptional profiling. This has led to the current generation of biomarker-driven clinical trials assigning WNT tumors to a favorable prognosis group in addition to clinicopathological criteria including MYC and MYCN gene amplifications. However, outcome prediction of non-WNT subgroups is a challenge due to inconsistent survival reports. In 2015, a consensus conference was convened in Heidelberg with the objective to further refine the risk stratification in the context of subgroups and agree on a definition of risk groups of non-infant, childhood medulloblastoma (ages 3–17). Published and unpublished data over the past 5 years were reviewed, and a consensus was reached regarding the level of evidence for currently available biomarkers. The following risk groups were defined based on current survival rates: low risk (>90 % survival), average (standard) risk (75–90 % survival), high risk (50–75 % survival) and very high risk (<50 % survival) disease. The WNT subgroup and non-metastatic Group 4 tumors with whole chromosome 11 loss or whole chromosome 17 gain were recognized as low-risk tumors that may qualify for reduced therapy. High-risk strata were defined as patients with metastatic SHH or Group 4 tumors, or MYCN-amplified SHH medulloblastomas. Very high-risk patients are Group 3 with metastases or SHH with TP53 mutation. In addition, a number of consensus points were reached that should be standardized across future clinical trials. Although we anticipate new data will emerge from currently ongoing and recently completed clinical trials, this consensus can serve as an outline for prioritization of certain molecular subsets of tumors to define and validate risk groups as a basis for future clinical trials.
         datePublished:2016-04-04T00:00:00Z
         dateModified:2016-04-04T00:00:00Z
         pageStart:821
         pageEnd:831
         sameAs:https://doi.org/10.1007/s00401-016-1569-6
         keywords:
            Medulloblastoma
            Subgroups
            WNT
            SHH
            Group 3
            Group 4
            p53
            Genomics
            Outcomes
            Pathology
            Neurosciences
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00401-016-1569-6/MediaObjects/401_2016_1569_Fig1_HTML.gif
         isPartOf:
            name:Acta Neuropathologica
            issn:
               1432-0533
               0001-6322
            volumeNumber:131
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer Berlin Heidelberg
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Vijay Ramaswamy
               affiliation:
                     name:Hospital for Sick Children
                     address:
                        name:Division of Haematology/Oncology, Hospital for Sick Children, Toronto, Canada
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Marc Remke
               affiliation:
                     name:University Hospital Düsseldorf
                     address:
                        name:Department of Pediatric Oncology, Hematology, and Clinical Immunology, University Hospital Düsseldorf, Düsseldorf, Germany
                        type:PostalAddress
                     type:Organization
                     name:German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ)
                     address:
                        name:Department of Pediatric Neuro-Oncogenomics, German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Düsseldorf, Germany
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Eric Bouffet
               affiliation:
                     name:Hospital for Sick Children
                     address:
                        name:Division of Haematology/Oncology, Hospital for Sick Children, Toronto, Canada
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Simon Bailey
               affiliation:
                     name:Newcastle University
                     address:
                        name:Northern Institute for Cancer Research, Newcastle University, Newcastle-upon-Tyne, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Steven C. Clifford
               affiliation:
                     name:Newcastle University
                     address:
                        name:Northern Institute for Cancer Research, Newcastle University, Newcastle-upon-Tyne, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Francois Doz
               affiliation:
                     name:Curie Institute, and University Paris Descartes
                     address:
                        name:Department of Paediatric, Adolescents and Young Adults Oncology, Curie Institute, and University Paris Descartes, Paris, France
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Marcel Kool
               affiliation:
                     name:DKFZ, and German Cancer Consortium (DKTK)
                     address:
                        name:Division of Pediatric Neurooncology (B062), DKFZ, and German Cancer Consortium (DKTK), Heidelberg, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Christelle Dufour
               affiliation:
                     name:Institut Gustave-Roussy
                     address:
                        name:Department of Pediatric and Adolescent Oncology, Institut Gustave-Roussy, Villejuif, France
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Gilles Vassal
               affiliation:
                     name:Institut Gustave-Roussy
                     address:
                        name:Department of Pediatric and Adolescent Oncology, Institut Gustave-Roussy, Villejuif, France
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Till Milde
               affiliation:
                     name:University Hospital Heidelberg
                     address:
                        name:Department of Pediatric Oncology, Hematology and Clinical Immunology, University Hospital Heidelberg, Heidelberg, Germany
                        type:PostalAddress
                     type:Organization
                     name:DKFZ
                     address:
                        name:Clinical Cooperation Unit Pediatric Oncology (G340), DKFZ, Heidelberg, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Olaf Witt
               affiliation:
                     name:University Hospital Heidelberg
                     address:
                        name:Department of Pediatric Oncology, Hematology and Clinical Immunology, University Hospital Heidelberg, Heidelberg, Germany
                        type:PostalAddress
                     type:Organization
                     name:DKFZ
                     address:
                        name:Clinical Cooperation Unit Pediatric Oncology (G340), DKFZ, Heidelberg, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Katja von Hoff
               affiliation:
                     name:University Medical Center Hamburg-Eppendorf
                     address:
                        name:Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Torsten Pietsch
               affiliation:
                     name:University of Bonn
                     address:
                        name:Neuropathology, University of Bonn, Bonn, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Paul A. Northcott
               affiliation:
                     name:St. Jude’s Research Hospital
                     address:
                        name:St. Jude’s Research Hospital, Memphis, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Amar Gajjar
               affiliation:
                     name:St. Jude’s Research Hospital
                     address:
                        name:St. Jude’s Research Hospital, Memphis, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Giles W. Robinson
               affiliation:
                     name:St. Jude’s Research Hospital
                     address:
                        name:St. Jude’s Research Hospital, Memphis, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Laetitia Padovani
               affiliation:
                     name:Aix-Marseille Université, Inserm, CRO2 UMR_S 911
                     address:
                        name:Aix-Marseille Université, Inserm, CRO2 UMR_S 911, Marseille Cedex 05, France
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Nicolas André
               affiliation:
                     name:AP-HM
                     address:
                        name:Department of Pediatric Hematology and Oncology, AP-HM, Marseille, France
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Maura Massimino
               affiliation:
                     name:Fondazione IRCCS “Istituto Nazionale dei Tumori”
                     address:
                        name:Fondazione IRCCS “Istituto Nazionale dei Tumori”, Milan, Italy
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Barry Pizer
               affiliation:
                     name:Alder Hey Children’s NHS Foundation Trust
                     address:
                        name:Department of Oncology, Alder Hey Children’s NHS Foundation Trust, Liverpool, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Roger Packer
               affiliation:
                     name:Children’s National Medical Center
                     address:
                        name:Department of Neurology, Children’s National Medical Center, Washington, DC, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Stefan Rutkowski
               affiliation:
                     name:University Medical Center Hamburg-Eppendorf
                     address:
                        name:Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Stefan M. Pfister
               affiliation:
                     name:DKFZ, and German Cancer Consortium (DKTK)
                     address:
                        name:Division of Pediatric Neurooncology (B062), DKFZ, and German Cancer Consortium (DKTK), Heidelberg, Germany
                        type:PostalAddress
                     type:Organization
                     name:University Hospital Heidelberg
                     address:
                        name:Department of Pediatric Oncology, Hematology and Clinical Immunology, University Hospital Heidelberg, Heidelberg, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Michael D. Taylor
               affiliation:
                     name:Hospital for Sick Children
                     address:
                        name:Division of Neurosurgery, Hospital for Sick Children, Toronto, Canada
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Scott L. Pomeroy
               affiliation:
                     name:Boston Children’s Hospital and Harvard Medical School
                     address:
                        name:Department of Neurology, Boston Children’s Hospital and Harvard Medical School, Boston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Risk stratification of childhood medulloblastoma in the molecular era: the current consensus
      description:Historical risk stratification criteria for medulloblastoma rely primarily on clinicopathological variables pertaining to age, presence of metastases, extent of resection, histological subtypes and in some instances individual genetic aberrations such as MYC and MYCN amplification. In 2010, an international panel of experts established consensus defining four main subgroups of medulloblastoma (WNT, SHH, Group 3 and Group 4) delineated by transcriptional profiling. This has led to the current generation of biomarker-driven clinical trials assigning WNT tumors to a favorable prognosis group in addition to clinicopathological criteria including MYC and MYCN gene amplifications. However, outcome prediction of non-WNT subgroups is a challenge due to inconsistent survival reports. In 2015, a consensus conference was convened in Heidelberg with the objective to further refine the risk stratification in the context of subgroups and agree on a definition of risk groups of non-infant, childhood medulloblastoma (ages 3–17). Published and unpublished data over the past 5 years were reviewed, and a consensus was reached regarding the level of evidence for currently available biomarkers. The following risk groups were defined based on current survival rates: low risk (>90 % survival), average (standard) risk (75–90 % survival), high risk (50–75 % survival) and very high risk (<50 % survival) disease. The WNT subgroup and non-metastatic Group 4 tumors with whole chromosome 11 loss or whole chromosome 17 gain were recognized as low-risk tumors that may qualify for reduced therapy. High-risk strata were defined as patients with metastatic SHH or Group 4 tumors, or MYCN-amplified SHH medulloblastomas. Very high-risk patients are Group 3 with metastases or SHH with TP53 mutation. In addition, a number of consensus points were reached that should be standardized across future clinical trials. Although we anticipate new data will emerge from currently ongoing and recently completed clinical trials, this consensus can serve as an outline for prioritization of certain molecular subsets of tumors to define and validate risk groups as a basis for future clinical trials.
      datePublished:2016-04-04T00:00:00Z
      dateModified:2016-04-04T00:00:00Z
      pageStart:821
      pageEnd:831
      sameAs:https://doi.org/10.1007/s00401-016-1569-6
      keywords:
         Medulloblastoma
         Subgroups
         WNT
         SHH
         Group 3
         Group 4
         p53
         Genomics
         Outcomes
         Pathology
         Neurosciences
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00401-016-1569-6/MediaObjects/401_2016_1569_Fig1_HTML.gif
      isPartOf:
         name:Acta Neuropathologica
         issn:
            1432-0533
            0001-6322
         volumeNumber:131
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer Berlin Heidelberg
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Vijay Ramaswamy
            affiliation:
                  name:Hospital for Sick Children
                  address:
                     name:Division of Haematology/Oncology, Hospital for Sick Children, Toronto, Canada
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Marc Remke
            affiliation:
                  name:University Hospital Düsseldorf
                  address:
                     name:Department of Pediatric Oncology, Hematology, and Clinical Immunology, University Hospital Düsseldorf, Düsseldorf, Germany
                     type:PostalAddress
                  type:Organization
                  name:German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ)
                  address:
                     name:Department of Pediatric Neuro-Oncogenomics, German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Düsseldorf, Germany
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Eric Bouffet
            affiliation:
                  name:Hospital for Sick Children
                  address:
                     name:Division of Haematology/Oncology, Hospital for Sick Children, Toronto, Canada
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Simon Bailey
            affiliation:
                  name:Newcastle University
                  address:
                     name:Northern Institute for Cancer Research, Newcastle University, Newcastle-upon-Tyne, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Steven C. Clifford
            affiliation:
                  name:Newcastle University
                  address:
                     name:Northern Institute for Cancer Research, Newcastle University, Newcastle-upon-Tyne, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Francois Doz
            affiliation:
                  name:Curie Institute, and University Paris Descartes
                  address:
                     name:Department of Paediatric, Adolescents and Young Adults Oncology, Curie Institute, and University Paris Descartes, Paris, France
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Marcel Kool
            affiliation:
                  name:DKFZ, and German Cancer Consortium (DKTK)
                  address:
                     name:Division of Pediatric Neurooncology (B062), DKFZ, and German Cancer Consortium (DKTK), Heidelberg, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Christelle Dufour
            affiliation:
                  name:Institut Gustave-Roussy
                  address:
                     name:Department of Pediatric and Adolescent Oncology, Institut Gustave-Roussy, Villejuif, France
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Gilles Vassal
            affiliation:
                  name:Institut Gustave-Roussy
                  address:
                     name:Department of Pediatric and Adolescent Oncology, Institut Gustave-Roussy, Villejuif, France
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Till Milde
            affiliation:
                  name:University Hospital Heidelberg
                  address:
                     name:Department of Pediatric Oncology, Hematology and Clinical Immunology, University Hospital Heidelberg, Heidelberg, Germany
                     type:PostalAddress
                  type:Organization
                  name:DKFZ
                  address:
                     name:Clinical Cooperation Unit Pediatric Oncology (G340), DKFZ, Heidelberg, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Olaf Witt
            affiliation:
                  name:University Hospital Heidelberg
                  address:
                     name:Department of Pediatric Oncology, Hematology and Clinical Immunology, University Hospital Heidelberg, Heidelberg, Germany
                     type:PostalAddress
                  type:Organization
                  name:DKFZ
                  address:
                     name:Clinical Cooperation Unit Pediatric Oncology (G340), DKFZ, Heidelberg, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Katja von Hoff
            affiliation:
                  name:University Medical Center Hamburg-Eppendorf
                  address:
                     name:Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Torsten Pietsch
            affiliation:
                  name:University of Bonn
                  address:
                     name:Neuropathology, University of Bonn, Bonn, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Paul A. Northcott
            affiliation:
                  name:St. Jude’s Research Hospital
                  address:
                     name:St. Jude’s Research Hospital, Memphis, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Amar Gajjar
            affiliation:
                  name:St. Jude’s Research Hospital
                  address:
                     name:St. Jude’s Research Hospital, Memphis, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Giles W. Robinson
            affiliation:
                  name:St. Jude’s Research Hospital
                  address:
                     name:St. Jude’s Research Hospital, Memphis, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Laetitia Padovani
            affiliation:
                  name:Aix-Marseille Université, Inserm, CRO2 UMR_S 911
                  address:
                     name:Aix-Marseille Université, Inserm, CRO2 UMR_S 911, Marseille Cedex 05, France
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Nicolas André
            affiliation:
                  name:AP-HM
                  address:
                     name:Department of Pediatric Hematology and Oncology, AP-HM, Marseille, France
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Maura Massimino
            affiliation:
                  name:Fondazione IRCCS “Istituto Nazionale dei Tumori”
                  address:
                     name:Fondazione IRCCS “Istituto Nazionale dei Tumori”, Milan, Italy
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Barry Pizer
            affiliation:
                  name:Alder Hey Children’s NHS Foundation Trust
                  address:
                     name:Department of Oncology, Alder Hey Children’s NHS Foundation Trust, Liverpool, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Roger Packer
            affiliation:
                  name:Children’s National Medical Center
                  address:
                     name:Department of Neurology, Children’s National Medical Center, Washington, DC, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Stefan Rutkowski
            affiliation:
                  name:University Medical Center Hamburg-Eppendorf
                  address:
                     name:Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Stefan M. Pfister
            affiliation:
                  name:DKFZ, and German Cancer Consortium (DKTK)
                  address:
                     name:Division of Pediatric Neurooncology (B062), DKFZ, and German Cancer Consortium (DKTK), Heidelberg, Germany
                     type:PostalAddress
                  type:Organization
                  name:University Hospital Heidelberg
                  address:
                     name:Department of Pediatric Oncology, Hematology and Clinical Immunology, University Hospital Heidelberg, Heidelberg, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Michael D. Taylor
            affiliation:
                  name:Hospital for Sick Children
                  address:
                     name:Division of Neurosurgery, Hospital for Sick Children, Toronto, Canada
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Scott L. Pomeroy
            affiliation:
                  name:Boston Children’s Hospital and Harvard Medical School
                  address:
                     name:Department of Neurology, Boston Children’s Hospital and Harvard Medical School, Boston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Acta Neuropathologica
      issn:
         1432-0533
         0001-6322
      volumeNumber:131
Organization:
      name:Springer Berlin Heidelberg
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Hospital for Sick Children
      address:
         name:Division of Haematology/Oncology, Hospital for Sick Children, Toronto, Canada
         type:PostalAddress
      name:University Hospital Düsseldorf
      address:
         name:Department of Pediatric Oncology, Hematology, and Clinical Immunology, University Hospital Düsseldorf, Düsseldorf, Germany
         type:PostalAddress
      name:German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ)
      address:
         name:Department of Pediatric Neuro-Oncogenomics, German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Düsseldorf, Germany
         type:PostalAddress
      name:Hospital for Sick Children
      address:
         name:Division of Haematology/Oncology, Hospital for Sick Children, Toronto, Canada
         type:PostalAddress
      name:Newcastle University
      address:
         name:Northern Institute for Cancer Research, Newcastle University, Newcastle-upon-Tyne, UK
         type:PostalAddress
      name:Newcastle University
      address:
         name:Northern Institute for Cancer Research, Newcastle University, Newcastle-upon-Tyne, UK
         type:PostalAddress
      name:Curie Institute, and University Paris Descartes
      address:
         name:Department of Paediatric, Adolescents and Young Adults Oncology, Curie Institute, and University Paris Descartes, Paris, France
         type:PostalAddress
      name:DKFZ, and German Cancer Consortium (DKTK)
      address:
         name:Division of Pediatric Neurooncology (B062), DKFZ, and German Cancer Consortium (DKTK), Heidelberg, Germany
         type:PostalAddress
      name:Institut Gustave-Roussy
      address:
         name:Department of Pediatric and Adolescent Oncology, Institut Gustave-Roussy, Villejuif, France
         type:PostalAddress
      name:Institut Gustave-Roussy
      address:
         name:Department of Pediatric and Adolescent Oncology, Institut Gustave-Roussy, Villejuif, France
         type:PostalAddress
      name:University Hospital Heidelberg
      address:
         name:Department of Pediatric Oncology, Hematology and Clinical Immunology, University Hospital Heidelberg, Heidelberg, Germany
         type:PostalAddress
      name:DKFZ
      address:
         name:Clinical Cooperation Unit Pediatric Oncology (G340), DKFZ, Heidelberg, Germany
         type:PostalAddress
      name:University Hospital Heidelberg
      address:
         name:Department of Pediatric Oncology, Hematology and Clinical Immunology, University Hospital Heidelberg, Heidelberg, Germany
         type:PostalAddress
      name:DKFZ
      address:
         name:Clinical Cooperation Unit Pediatric Oncology (G340), DKFZ, Heidelberg, Germany
         type:PostalAddress
      name:University Medical Center Hamburg-Eppendorf
      address:
         name:Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
         type:PostalAddress
      name:University of Bonn
      address:
         name:Neuropathology, University of Bonn, Bonn, Germany
         type:PostalAddress
      name:St. Jude’s Research Hospital
      address:
         name:St. Jude’s Research Hospital, Memphis, USA
         type:PostalAddress
      name:St. Jude’s Research Hospital
      address:
         name:St. Jude’s Research Hospital, Memphis, USA
         type:PostalAddress
      name:St. Jude’s Research Hospital
      address:
         name:St. Jude’s Research Hospital, Memphis, USA
         type:PostalAddress
      name:Aix-Marseille Université, Inserm, CRO2 UMR_S 911
      address:
         name:Aix-Marseille Université, Inserm, CRO2 UMR_S 911, Marseille Cedex 05, France
         type:PostalAddress
      name:AP-HM
      address:
         name:Department of Pediatric Hematology and Oncology, AP-HM, Marseille, France
         type:PostalAddress
      name:Fondazione IRCCS “Istituto Nazionale dei Tumori”
      address:
         name:Fondazione IRCCS “Istituto Nazionale dei Tumori”, Milan, Italy
         type:PostalAddress
      name:Alder Hey Children’s NHS Foundation Trust
      address:
         name:Department of Oncology, Alder Hey Children’s NHS Foundation Trust, Liverpool, UK
         type:PostalAddress
      name:Children’s National Medical Center
      address:
         name:Department of Neurology, Children’s National Medical Center, Washington, DC, USA
         type:PostalAddress
      name:University Medical Center Hamburg-Eppendorf
      address:
         name:Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
         type:PostalAddress
      name:DKFZ, and German Cancer Consortium (DKTK)
      address:
         name:Division of Pediatric Neurooncology (B062), DKFZ, and German Cancer Consortium (DKTK), Heidelberg, Germany
         type:PostalAddress
      name:University Hospital Heidelberg
      address:
         name:Department of Pediatric Oncology, Hematology and Clinical Immunology, University Hospital Heidelberg, Heidelberg, Germany
         type:PostalAddress
      name:Hospital for Sick Children
      address:
         name:Division of Neurosurgery, Hospital for Sick Children, Toronto, Canada
         type:PostalAddress
      name:Boston Children’s Hospital and Harvard Medical School
      address:
         name:Department of Neurology, Boston Children’s Hospital and Harvard Medical School, Boston, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Vijay Ramaswamy
      affiliation:
            name:Hospital for Sick Children
            address:
               name:Division of Haematology/Oncology, Hospital for Sick Children, Toronto, Canada
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Marc Remke
      affiliation:
            name:University Hospital Düsseldorf
            address:
               name:Department of Pediatric Oncology, Hematology, and Clinical Immunology, University Hospital Düsseldorf, Düsseldorf, Germany
               type:PostalAddress
            type:Organization
            name:German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ)
            address:
               name:Department of Pediatric Neuro-Oncogenomics, German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Düsseldorf, Germany
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Eric Bouffet
      affiliation:
            name:Hospital for Sick Children
            address:
               name:Division of Haematology/Oncology, Hospital for Sick Children, Toronto, Canada
               type:PostalAddress
            type:Organization
      name:Simon Bailey
      affiliation:
            name:Newcastle University
            address:
               name:Northern Institute for Cancer Research, Newcastle University, Newcastle-upon-Tyne, UK
               type:PostalAddress
            type:Organization
      name:Steven C. Clifford
      affiliation:
            name:Newcastle University
            address:
               name:Northern Institute for Cancer Research, Newcastle University, Newcastle-upon-Tyne, UK
               type:PostalAddress
            type:Organization
      name:Francois Doz
      affiliation:
            name:Curie Institute, and University Paris Descartes
            address:
               name:Department of Paediatric, Adolescents and Young Adults Oncology, Curie Institute, and University Paris Descartes, Paris, France
               type:PostalAddress
            type:Organization
      name:Marcel Kool
      affiliation:
            name:DKFZ, and German Cancer Consortium (DKTK)
            address:
               name:Division of Pediatric Neurooncology (B062), DKFZ, and German Cancer Consortium (DKTK), Heidelberg, Germany
               type:PostalAddress
            type:Organization
      name:Christelle Dufour
      affiliation:
            name:Institut Gustave-Roussy
            address:
               name:Department of Pediatric and Adolescent Oncology, Institut Gustave-Roussy, Villejuif, France
               type:PostalAddress
            type:Organization
      name:Gilles Vassal
      affiliation:
            name:Institut Gustave-Roussy
            address:
               name:Department of Pediatric and Adolescent Oncology, Institut Gustave-Roussy, Villejuif, France
               type:PostalAddress
            type:Organization
      name:Till Milde
      affiliation:
            name:University Hospital Heidelberg
            address:
               name:Department of Pediatric Oncology, Hematology and Clinical Immunology, University Hospital Heidelberg, Heidelberg, Germany
               type:PostalAddress
            type:Organization
            name:DKFZ
            address:
               name:Clinical Cooperation Unit Pediatric Oncology (G340), DKFZ, Heidelberg, Germany
               type:PostalAddress
            type:Organization
      name:Olaf Witt
      affiliation:
            name:University Hospital Heidelberg
            address:
               name:Department of Pediatric Oncology, Hematology and Clinical Immunology, University Hospital Heidelberg, Heidelberg, Germany
               type:PostalAddress
            type:Organization
            name:DKFZ
            address:
               name:Clinical Cooperation Unit Pediatric Oncology (G340), DKFZ, Heidelberg, Germany
               type:PostalAddress
            type:Organization
      name:Katja von Hoff
      affiliation:
            name:University Medical Center Hamburg-Eppendorf
            address:
               name:Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
               type:PostalAddress
            type:Organization
      name:Torsten Pietsch
      affiliation:
            name:University of Bonn
            address:
               name:Neuropathology, University of Bonn, Bonn, Germany
               type:PostalAddress
            type:Organization
      name:Paul A. Northcott
      affiliation:
            name:St. Jude’s Research Hospital
            address:
               name:St. Jude’s Research Hospital, Memphis, USA
               type:PostalAddress
            type:Organization
      name:Amar Gajjar
      affiliation:
            name:St. Jude’s Research Hospital
            address:
               name:St. Jude’s Research Hospital, Memphis, USA
               type:PostalAddress
            type:Organization
      name:Giles W. Robinson
      affiliation:
            name:St. Jude’s Research Hospital
            address:
               name:St. Jude’s Research Hospital, Memphis, USA
               type:PostalAddress
            type:Organization
      name:Laetitia Padovani
      affiliation:
            name:Aix-Marseille Université, Inserm, CRO2 UMR_S 911
            address:
               name:Aix-Marseille Université, Inserm, CRO2 UMR_S 911, Marseille Cedex 05, France
               type:PostalAddress
            type:Organization
      name:Nicolas André
      affiliation:
            name:AP-HM
            address:
               name:Department of Pediatric Hematology and Oncology, AP-HM, Marseille, France
               type:PostalAddress
            type:Organization
      name:Maura Massimino
      affiliation:
            name:Fondazione IRCCS “Istituto Nazionale dei Tumori”
            address:
               name:Fondazione IRCCS “Istituto Nazionale dei Tumori”, Milan, Italy
               type:PostalAddress
            type:Organization
      name:Barry Pizer
      affiliation:
            name:Alder Hey Children’s NHS Foundation Trust
            address:
               name:Department of Oncology, Alder Hey Children’s NHS Foundation Trust, Liverpool, UK
               type:PostalAddress
            type:Organization
      name:Roger Packer
      affiliation:
            name:Children’s National Medical Center
            address:
               name:Department of Neurology, Children’s National Medical Center, Washington, DC, USA
               type:PostalAddress
            type:Organization
      name:Stefan Rutkowski
      affiliation:
            name:University Medical Center Hamburg-Eppendorf
            address:
               name:Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
               type:PostalAddress
            type:Organization
      name:Stefan M. Pfister
      affiliation:
            name:DKFZ, and German Cancer Consortium (DKTK)
            address:
               name:Division of Pediatric Neurooncology (B062), DKFZ, and German Cancer Consortium (DKTK), Heidelberg, Germany
               type:PostalAddress
            type:Organization
            name:University Hospital Heidelberg
            address:
               name:Department of Pediatric Oncology, Hematology and Clinical Immunology, University Hospital Heidelberg, Heidelberg, Germany
               type:PostalAddress
            type:Organization
      name:Michael D. Taylor
      affiliation:
            name:Hospital for Sick Children
            address:
               name:Division of Neurosurgery, Hospital for Sick Children, Toronto, Canada
               type:PostalAddress
            type:Organization
      name:Scott L. Pomeroy
      affiliation:
            name:Boston Children’s Hospital and Harvard Medical School
            address:
               name:Department of Neurology, Boston Children’s Hospital and Harvard Medical School, Boston, USA
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Division of Haematology/Oncology, Hospital for Sick Children, Toronto, Canada
      name:Department of Pediatric Oncology, Hematology, and Clinical Immunology, University Hospital Düsseldorf, Düsseldorf, Germany
      name:Department of Pediatric Neuro-Oncogenomics, German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Düsseldorf, Germany
      name:Division of Haematology/Oncology, Hospital for Sick Children, Toronto, Canada
      name:Northern Institute for Cancer Research, Newcastle University, Newcastle-upon-Tyne, UK
      name:Northern Institute for Cancer Research, Newcastle University, Newcastle-upon-Tyne, UK
      name:Department of Paediatric, Adolescents and Young Adults Oncology, Curie Institute, and University Paris Descartes, Paris, France
      name:Division of Pediatric Neurooncology (B062), DKFZ, and German Cancer Consortium (DKTK), Heidelberg, Germany
      name:Department of Pediatric and Adolescent Oncology, Institut Gustave-Roussy, Villejuif, France
      name:Department of Pediatric and Adolescent Oncology, Institut Gustave-Roussy, Villejuif, France
      name:Department of Pediatric Oncology, Hematology and Clinical Immunology, University Hospital Heidelberg, Heidelberg, Germany
      name:Clinical Cooperation Unit Pediatric Oncology (G340), DKFZ, Heidelberg, Germany
      name:Department of Pediatric Oncology, Hematology and Clinical Immunology, University Hospital Heidelberg, Heidelberg, Germany
      name:Clinical Cooperation Unit Pediatric Oncology (G340), DKFZ, Heidelberg, Germany
      name:Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
      name:Neuropathology, University of Bonn, Bonn, Germany
      name:St. Jude’s Research Hospital, Memphis, USA
      name:St. Jude’s Research Hospital, Memphis, USA
      name:St. Jude’s Research Hospital, Memphis, USA
      name:Aix-Marseille Université, Inserm, CRO2 UMR_S 911, Marseille Cedex 05, France
      name:Department of Pediatric Hematology and Oncology, AP-HM, Marseille, France
      name:Fondazione IRCCS “Istituto Nazionale dei Tumori”, Milan, Italy
      name:Department of Oncology, Alder Hey Children’s NHS Foundation Trust, Liverpool, UK
      name:Department of Neurology, Children’s National Medical Center, Washington, DC, USA
      name:Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
      name:Division of Pediatric Neurooncology (B062), DKFZ, and German Cancer Consortium (DKTK), Heidelberg, Germany
      name:Department of Pediatric Oncology, Hematology and Clinical Immunology, University Hospital Heidelberg, Heidelberg, Germany
      name:Division of Neurosurgery, Hospital for Sick Children, Toronto, Canada
      name:Department of Neurology, Boston Children’s Hospital and Harvard Medical School, Boston, USA
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(324)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

5.25s.

LINK . SPRINGER . COM {}